Anxiety and Depression Levels in Patients with Rheumatoid Arthritis
Objectives: The purpose of this study was to investigate the anxiety and depression levels in patients with rheumatoid arthritis (RA), which is a chronic disease progressing with intermittent arthralgia.
Methods: This prospective study consisted of 50 RA patients followed clinically in the rheumatology clinic and 50 patients with arthralgia excluding the diagnosis of RA forming a control group. The mean age of the patient group was 50.70±12.48 years, and 78% of the sample were women. The mean age of the control group was 38.46±10.88 years, and 54% of the sample were women. In the RA patient population, the mean duration of disease was 145.56±105.97 months. Beck Depression Inventory-II (BDI-II), Spielberger’s State-Trait Anxiety Inventory (STAI), Health Assessment Questionnaire (HAQ), and Disease Activity Score for Rheumatoid Arthritis (DAS28) scores were recorded and analyzed. The patient and control groups were subdivided according to age, sex, and educational level. The patient group included a larger number of people with less formal education then the control group.
Results: The DAS28 score was low or absent (remission) in 78% of the patients and HAQ-DI score of the patients was significantly higher than in the control group (p=0.001; p<0.01). STAI results indicated that both groups had primarily trait anxiety (STAI-T). Both groups also had minimal depression, according to BDI-II scores. Correlations between scores were evaluated, and a positive relationship between the BDI–II and HAQ-DI scores of the patients and the STAI-T and HAQ-DI of the control group (p<0.001) was observed. There was no other statistically significant relationship between scores.
Conclusion: Anxiety and depression levels was not significantly associated with disease activity in patients with rheumatoid arthritis. Due to fact that, 78 of of the patients was in remission state, the patients had minimal depression state. Remission state of the disease did not cause anxiety and depression. Further researchs are needed to enlight the association between rheumatoid arhtritis disease activity and anxiety and depression levels .
1.McCarty DJ, Koopman WJ. Arthritis and allied conditions : a textbook of rheumatology. 12th ed. Philadelphia: Lea & Febiger; 1993. p. 781–805.
2. Tugwell P, Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee. J Rheumatol 1993;20:555–6.
3. Anderson JJ, Chernoff MC. Sensitivity to change of rheumatoid arthritis clinical trial outcome measures. J Rheumatol 1993;20:535–7.
4. Dominick KL, Ahern FM, Gold CH, Heller DA. Health-related quality of life among older adults with arthritis. Health Qual Life Outcomes 2004;2:5. [CrossRef]
5. Magni G, Caldieron C, Rigatti-Luchini S, Merskey H. Chronic musculoskeletal pain and depressive symptoms in the general population. An analysis of the 1st National Health and Nutrition Examination Survey data. Pain 1990;43:299–307. [CrossRef]
6. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988;145:976–81. [CrossRef]
7. Hagglund KJ, Roth DL, Haley WE, Alarcón GS. Discriminant and convergent validity of self-report measures of affective distress in patients with rheumatoid arthritis. J Rheumatol 1989;16:1428–32.
8. Blalock SJ, DeVellis RF, Brown GK, Wallston KA. Validity of the Center for Epidemiological Studies Depression Scale in arthritis populations. Arthritis Rheum 1989;32:991–7. [CrossRef]
9. Murphy S, Creed F, Jayson MI. Psychiatric disorder and illness behaviour in rheumatoid arthritis. Br J Rheumatol 1988;27:357–63. [CrossRef]
10. Pastor Oliver JF, Morales Suárez-Varela M, Llopis González A, Ferriol Casar V. Prevalence and depression degree in patients with rheumatoid arthritis. Med Clin (Barc) 1998;111:361–6.
11. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569–81. [CrossRef]
12. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893–7. [CrossRef]
13. Ulusoy M, Sahin NH, Erkmen H. Turkish Version of The Beck Anxiety Inventory Psychometric Properties. J Cogn Psychother Int Q 1998;12:163–72.
14. Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005;23:S14–S18.
15. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8. [CrossRef]
16. Tarhan H, Cakmak O, Unal E, Akarken I, Un S, Ekin RG, et al. The effect of video-based education on patient anxiety in men undergoing transrectal prostate biopsy. Can Urol Assoc J 2014;8:E894–900. [CrossRef]
17. Hawley DJ, Wolfe F. Anxiety and depression in patients with rheumatoid arthritis: a prospective study of 400 patients. J Rheumatol 1988;15:932–41.
18. Mattussek S, Raspe HH. Arthritic pain and psychological distress in patients with chronic polyarthritis. Z Rheumatol 1989;48:229–35.
19. Affleck G, Tennen H, Urrows S, Higgins P. Individual differences in the day-to-day experience of chronic pain: a prospective daily study of rheumatoid arthritis patients. Health Psychol 1991;10:419–26. [CrossRef]
20. Guillemin F, Briançon S, Pourel J. Validity and discriminant ability of the HAQ Functional Index in early rheumatoid arthritis. Disabil Rehabil 1992;14:71–7. [CrossRef]
21. Ramey DR, Raynauld JP, Fries JF. The health assessment questionnaire 1992: status and review. Arthritis Care Res 1992;5:119–29. [CrossRef]
22. Smedstad LM, Vaglum P, Kvien TK, Moum T. The relationship between self-reported pain and sociodemographic variables, anxiety, and depressive symptoms in rheumatoid arthritis. J Rheumatol 1995;22:514–20.
23. Abdel-Nasser AM, Abd El-Azim S, Taal E, El-Badawy SA, Rasker JJ, Valkenburg HA. Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants. Br J Rheumatol 1998;37:391–7. [CrossRef]
24. Clemmey PA, Nicassio PM. Illness self-schemas in depressed and nondepressed rheumatoid arthritis patients. J Behav Med 1997;20:273–90. [CrossRef]
25. Arango MA, Cano PO. A potential moderating role of stress in the association of disease activity and psychological status among patients with rheumatoid arthritis. Psychol Rep 1998;83:147–57. [CrossRef]